Literature DB >> 26209187

Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.

Yohko Nakagawa1, Yasuyuki Negishi2, Masumi Shimizu2, Megumi Takahashi2, Masao Ichikawa3, Hidemi Takahashi2.   

Abstract

The major effector cells for cellular adaptive immunity are CD8(+) cytotoxic T lymphocytes (CTLs), which can recognize and kill virus-infected cells and tumor cells. Although CTLs exhibit strong cytolytic activity against target cells in vitro, a number of studies have demonstrated that their function is often impaired within tumors. Nevertheless, CTLs can regain their cytotoxic ability after escaping from the tumor environment, suggesting that the milieu created by tumors may affect the function of CTLs. As for the tumor environment, the patho-physiological situation present in vivo has been shown to differ from in vitro experimental conditions. In particular, low pH and hypoxia are the most important microenvironmental factors within growing tumors. In the present study, to determine the effect of these factors on CTL function in vivo, we examined the cytolytic activity of CTLs against their targets using murine CTL lines and the induction of these cells from memory cells under low pH or hypoxic conditions using antigen-primed spleen cells. The results indicated that both cytotoxic activity and the induction of functional CTLs were markedly inhibited under low pH. In contrast, in hypoxic conditions, although cytotoxic activity was almost unchanged, the induction of CTLs in vitro showed a slight enhancement, which was completely abrogated in low pH conditions. Therefore, antigen-specific CTL functions may be more vulnerable to low pH than to the oxygen concentration in vivo. The findings shown here provide new therapeutic approaches for controlling tumor growth by retaining CTL cytotoxicity through the maintenance of higher pH conditions.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxic T lymphocytes; Extracellular pH; Hypoxia; Low pH

Mesh:

Substances:

Year:  2015        PMID: 26209187     DOI: 10.1016/j.imlet.2015.07.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  37 in total

1.  Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.

Authors:  Stephen Mf Jamieson; Peter Tsai; Maria K Kondratyev; Pratha Budhani; Arthur Liu; Neil N Senzer; E Gabriela Chiorean; Shadia I Jalal; John J Nemunaitis; Dennis Kee; Avik Shome; Way W Wong; Dan Li; Nooriyah Poonawala-Lohani; Purvi M Kakadia; Nicholas S Knowlton; Courtney Rh Lynch; Cho R Hong; Tet Woo Lee; Reidar A Grénman; Laura Caporiccio; Trevor D McKee; Mark Zaidi; Sehrish Butt; Andrew Mj Macann; Nicholas P McIvor; John M Chaplin; Kevin O Hicks; Stefan K Bohlander; Bradly G Wouters; Charles P Hart; Cristin G Print; William R Wilson; Michael A Curran; Francis W Hunter
Journal:  JCI Insight       Date:  2018-08-23

Review 2.  Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.

Authors:  Quoc-Viet Le; Juhan Suh; Yu-Kyoung Oh
Journal:  AAPS J       Date:  2019-05-17       Impact factor: 4.009

3.  Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.

Authors:  Kelsey E Huntington; Anna Louie; Lanlan Zhou; Attila A Seyhan; Aaron Wp Maxwell; Wafik S El-Deiry
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 4.  Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.

Authors:  S Chouaib; M Z Noman; K Kosmatopoulos; M A Curran
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

5.  Metabolic requirements of Besnoitia besnoiti tachyzoite-triggered NETosis.

Authors:  Ershun Zhou; Iván Conejeros; Ulrich Gärtner; Sybille Mazurek; Carlos Hermosilla; Anja Taubert
Journal:  Parasitol Res       Date:  2019-11-28       Impact factor: 2.289

Review 6.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

Review 7.  Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy.

Authors:  Ezekiel Maloney; Tanya Khokhlova; Venu G Pillarisetty; George R Schade; Elizabeth A Repasky; Yak-Nam Wang; Lorenzo Giuliani; Matteo Primavera; Joo Ha Hwang
Journal:  Int Rev Immunol       Date:  2017-09-29       Impact factor: 5.311

8.  Intratumoral Hypoxia Reduces IFN-γ-Mediated Immunity and MHC Class I Induction in a Preclinical Tumor Model.

Authors:  Aditi Murthy; Scott A Gerber; Cameron J Koch; Edith M Lord
Journal:  Immunohorizons       Date:  2019-04-29

Review 9.  CAR T-cell immunotherapy: The path from the by-road to the freeway?

Authors:  Lynsey M Whilding; John Maher
Journal:  Mol Oncol       Date:  2015-10-23       Impact factor: 6.603

Review 10.  Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer.

Authors:  Violet Y Tu; Asma Ayari; Roddy S O'Connor
Journal:  Antibodies (Basel)       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.